Samsung Bioepis to start phase 1 trial of pancreatitis drug SB26

Image: Samsung Bioepis to initiate phase 1 trial of SB26 ulinastatin-Fc fusion protein. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.